Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-21-046054

COO, CFO sold 4,500 shares at $33.75 ($151,875)

  • COO, CFO acquired 4,500 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Kung Winston · COO, CFO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-07-08 Exercise or conversion : show line 1 in the form +4,500 $3.22 $14,490 6,100 D
2021-07-08 Sale : show line 2 in the form −4,500 $33.75 $151,875 1,600 D
Open-market sales · 4,500 sh · avg $33.75 · $151,875

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-07-08 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −4,500 223,534 D
Loading xslF345X03/doc4.xml…